Royalty Pharma plc portfolio

No portfolio holdings are available yet.

Save to watchlist Sign in to save
Manager details and filing context
Latest 13F filing
Q2 2026 - 21 Aug 2026
13F snapshot Latest parsed holdings, value, and filing-period context. 1 signal
Form 13F summary
  • Royalty Pharma plc Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
  • Form 13F is generally due within 45 days after each calendar quarter ends.
  • <a href="/investor/0002081668-royalty-pharma-sub-manager-llc">Royalty Pharma Sub-Manager, LLC</a> is reporting for Royalty Pharma plc.
Manager Names, identifiers, and filing context for this profile. 1 identity field
Manager location
New York, NY

Royalty Pharma Sub-Manager, LLC is reporting for Royalty Pharma plc:

Name Holdings Value Location File Number
Royalty Pharma Sub-Manager, LLC $241,917,580 New York, NY 028-26787
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .